Cell Culture Models and Pharmacological Perspective for the Study of Breast Cancer Markers.
Among the most prevalent neoplasias, breast cancer shows an astonishing tendency. Unfortunately this cancer has a high mortality worldwide, requiring sustained management of all actors involved in public health in order to get an early diagnosis and treatment. The methods associated with conventional cytogenetics and molecular cell culture, besides early detection of gene expression patterns associated with cancer susceptibility, have contributed to identify inherited genes and metabolic disorders related to obesity, which are also involved in breast cancer. In any case, a broad study of the above mentioned factors can give a predictive value to support the design of public health models to determine cancer risk in order to decrease the mortality from this disease. (1) Cell cultures offers a wide range of scientific approach for the study of breast cancer, including the analysis of biological function of several compounds in search of increasingly effective treatments with fewer side effects against this malignancy. (2).
International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), Professional Scientific Exchange Programme, Sustainable Chemistry Research Center (CIQS) Autonomous University of the State of Mexico (UAEMex), National Autonomous University of México (UNAM).
Cristian Layton
CL
Tovar
Medical Research Center (CICMED), UAEMex; Asociación Científica Latina (ASCILA) and Ciprés Grupo Médico (CGM) , Toluca, Mexico.
Hugo Mendieta
HM
Zerón
breast cancer; cancer markers; cell culture; cytogenetic
Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3761-6
21321214
Cancer Cell Int. 2010 Sep 15;10:34
20840789
J Mol Signal. 2010 Jul 12;5:8
20624308
Ann Oncol. 2005 Nov;16(11):1723-39
15980158
BMJ. 2000 Sep 9;321(7261):624-8
10977847
PLoS One. 2010 Sep 20;5(9):e12860
20877462
Eur J Cancer. 1991;27(8):977-80
1832907
Mol Cancer Ther. 2002 Jun;1(8):611-6
12479221
World J Surg Oncol. 2011 Mar 16;9:31
21410943
Cancer Res. 1987 Jan 15;47(2):403-6
3491676
Cancer Res. 1991 Sep 1;51(17):4544-8
1873798
Hum Mutat. 2005 May;25(5):415-22
15832305
Lancet. 1987 Jun 20;1(8547):1398-402
2884496
Oncogene. 1995 Jul 20;11(2):211-9
7624138
Semin Cancer Biol. 2008 Oct;18(5):311-21
18455428